171 related articles for article (PubMed ID: 36876343)
1. From netrin-1-targeted SPECT/CT to internal radiotherapy for management of advanced solid tumors.
Kryza D; Wischhusen J; Richaud M; Hervieu M; Sidi Boumedine J; Delcros JG; Besse S; Baudier T; Laval PA; Breusa S; Boutault E; Clermidy H; Rama N; Ducarouge B; Devouassoux-Shisheboran M; Chezal JM; Giraudet AL; Walter T; Mehlen P; Sarrut D; Gibert B
EMBO Mol Med; 2023 Apr; 15(4):e16732. PubMed ID: 36876343
[TBL] [Abstract][Full Text] [Related]
2. Netrin-1 blockade inhibits tumour growth and EMT features in endometrial cancer.
Cassier PA; Navaridas R; Bellina M; Rama N; Ducarouge B; Hernandez-Vargas H; Delord JP; Lengrand J; Paradisi A; Fattet L; Garin G; Gheit H; Dalban C; Pastushenko I; Neves D; Jelin R; Gadot N; Braissand N; Léon S; Degletagne C; Matias-Guiu X; Devouassoux-Shisheboran M; Mery-Lamarche E; Allard J; Zindy E; Decaestecker C; Salmon I; Perol D; Dolcet X; Ray-Coquard I; Blanpain C; Bernet A; Mehlen P
Nature; 2023 Aug; 620(7973):409-416. PubMed ID: 37532934
[TBL] [Abstract][Full Text] [Related]
3. Targeting netrin-3 in small cell lung cancer and neuroblastoma.
Jiang S; Richaud M; Vieugué P; Rama N; Delcros JG; Siouda M; Sanada M; Redavid AR; Ducarouge B; Hervieu M; Breusa S; Manceau A; Gattolliat CH; Gadot N; Combaret V; Neves D; Ortiz-Cuaran S; Saintigny P; Meurette O; Walter T; Janoueix-Lerosey I; Hofman P; Mulligan P; Goldshneider D; Mehlen P; Gibert B
EMBO Mol Med; 2021 Apr; 13(4):e12878. PubMed ID: 33719214
[TBL] [Abstract][Full Text] [Related]
4. Netrin-1 expression and targeting in multiple myeloma.
Fahed D; Chettab A; Mathe D; Denis M; Traverse-Glehen A; Karlin L; Perrial E; Dumontet C
Leuk Lymphoma; 2022 Feb; 63(2):395-403. PubMed ID: 34585999
[TBL] [Abstract][Full Text] [Related]
5. Theranostic pretargeted radioimmunotherapy of internalizing solid tumor antigens in human tumor xenografts in mice: Curative treatment of HER2-positive breast carcinoma.
Cheal SM; Xu H; Guo HF; Patel M; Punzalan B; Fung EK; Lee SG; Bell M; Singh M; Jungbluth AA; Zanzonico PB; Piersigilli A; Larson SM; Cheung NV
Theranostics; 2018; 8(18):5106-5125. PubMed ID: 30429889
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological targeting of netrin-1 inhibits EMT in cancer.
Lengrand J; Pastushenko I; Vanuytven S; Song Y; Venet D; Sarate RM; Bellina M; Moers V; Boinet A; Sifrim A; Rama N; Ducarouge B; Van Herck J; Dubois C; Scozzaro S; Lemaire S; Gieskes S; Bonni S; Collin A; Braissand N; Allard J; Zindy E; Decaestecker C; Sotiriou C; Salmon I; Mehlen P; Voet T; Bernet A; Blanpain C
Nature; 2023 Aug; 620(7973):402-408. PubMed ID: 37532929
[TBL] [Abstract][Full Text] [Related]
7. Curative Multicycle Radioimmunotherapy Monitored by Quantitative SPECT/CT-Based Theranostics, Using Bispecific Antibody Pretargeting Strategy in Colorectal Cancer.
Cheal SM; Fung EK; Patel M; Xu H; Guo HF; Zanzonico PB; Monette S; Wittrup KD; Cheung NV; Larson SM
J Nucl Med; 2017 Nov; 58(11):1735-1742. PubMed ID: 28705917
[TBL] [Abstract][Full Text] [Related]
8. Preclinical efficacy of hK2 targeted [
Timmermand OV; Elgqvist J; Beattie KA; Örbom A; Larsson E; Eriksson SE; Thorek DLJ; Beattie BJ; Tran TA; Ulmert D; Strand SE
Theranostics; 2019; 9(8):2129-2142. PubMed ID: 31149033
[TBL] [Abstract][Full Text] [Related]
9. Ultrasound molecular imaging as a non-invasive companion diagnostic for netrin-1 interference therapy in breast cancer.
Wischhusen J; Wilson KE; Delcros JG; Molina-Peña R; Gibert B; Jiang S; Ngo J; Goldschneider D; Mehlen P; Willmann JK; Padilla F
Theranostics; 2018; 8(18):5126-5142. PubMed ID: 30429890
[TBL] [Abstract][Full Text] [Related]
10. 177Lu-labeled antibodies for EGFR-targeted SPECT/CT imaging and radioimmunotherapy in a preclinical head and neck carcinoma model.
Liu Z; Ma T; Liu H; Jin Z; Sun X; Zhao H; Shi J; Jia B; Li F; Wang F
Mol Pharm; 2014 Mar; 11(3):800-7. PubMed ID: 24472064
[TBL] [Abstract][Full Text] [Related]
11. Pretargeted radioimmunotherapy and SPECT imaging of peritoneal carcinomatosis using bioorthogonal click chemistry: probe selection and first proof-of-concept.
Rondon A; Schmitt S; Briat A; Ty N; Maigne L; Quintana M; Membreno R; Zeglis BM; Navarro-Teulon I; Pouget JP; Chezal JM; Miot-Noirault E; Moreau E; Degoul F
Theranostics; 2019; 9(22):6706-6718. PubMed ID: 31588245
[No Abstract] [Full Text] [Related]
12. Immuno-PET Imaging and Radioimmunotherapy of 64Cu-/177Lu-Labeled Anti-EGFR Antibody in Esophageal Squamous Cell Carcinoma Model.
Song IH; Lee TS; Park YS; Lee JS; Lee BC; Moon BS; An GI; Lee HW; Kim KI; Lee YJ; Kang JH; Lim SM
J Nucl Med; 2016 Jul; 57(7):1105-11. PubMed ID: 26917708
[TBL] [Abstract][Full Text] [Related]
13. Alpha radioimmunotherapy using
Cheal SM; McDevitt MR; Santich BH; Patel M; Yang G; Fung EK; Veach DR; Bell M; Ahad A; Vargas DB; Punzalan B; Pillarsetty NVK; Xu H; Guo HF; Monette S; Michel AO; Piersigilli A; Scheinberg DA; Ouerfelli O; Cheung NV; Larson SM
Theranostics; 2020; 10(25):11359-11375. PubMed ID: 33052220
[TBL] [Abstract][Full Text] [Related]
14. Anti-tax interacting protein-1 (TIP-1) monoclonal antibody targets human cancers.
Yan H; Kapoor V; Nguyen K; Akers WJ; Li H; Scott J; Laforest R; Rogers B; Thotala D; Hallahan D
Oncotarget; 2016 Jul; 7(28):43352-43362. PubMed ID: 27270318
[TBL] [Abstract][Full Text] [Related]
15. Combined VLA-4-Targeted Radionuclide Therapy and Immunotherapy in a Mouse Model of Melanoma.
Choi J; Beaino W; Fecek RJ; Fabian KPL; Laymon CM; Kurland BF; Storkus WJ; Anderson CJ
J Nucl Med; 2018 Dec; 59(12):1843-1849. PubMed ID: 29959213
[TBL] [Abstract][Full Text] [Related]
16. Quantitative immuno-SPECT monitoring of pretargeted radioimmunotherapy with a bispecific antibody in an intraperitoneal nude mouse model of human colon cancer.
Schoffelen R; van der Graaf WT; Sharkey RM; Franssen GM; McBride WJ; Chang CH; Bos DL; Goldenberg DM; Oyen WJ; Boerman OC
J Nucl Med; 2012 Dec; 53(12):1926-32. PubMed ID: 23081995
[TBL] [Abstract][Full Text] [Related]
17. Anti-L1CAM radioimmunotherapy is more effective with the radiolanthanide terbium-161 compared to lutetium-177 in an ovarian cancer model.
Grünberg J; Lindenblatt D; Dorrer H; Cohrs S; Zhernosekov K; Köster U; Türler A; Fischer E; Schibli R
Eur J Nucl Med Mol Imaging; 2014 Oct; 41(10):1907-15. PubMed ID: 24859811
[TBL] [Abstract][Full Text] [Related]
18. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
19. L1-CAM-targeted antibody therapy and (177)Lu-radioimmunotherapy of disseminated ovarian cancer.
Fischer E; Grünberg J; Cohrs S; Hohn A; Waldner-Knogler K; Jeger S; Zimmermann K; Novak-Hofer I; Schibli R
Int J Cancer; 2012 Jun; 130(11):2715-21. PubMed ID: 21796623
[TBL] [Abstract][Full Text] [Related]
20. Development of a Theranostic Convergence Bioradiopharmaceutical for Immuno-PET Based Radioimmunotherapy of L1CAM in Cholangiocarcinoma Model.
Song IH; Jeong MS; Hong HJ; Shin JI; Park YS; Woo SK; Moon BS; Kim KI; Lee YJ; Kang JH; Lee TS
Clin Cancer Res; 2019 Oct; 25(20):6148-6159. PubMed ID: 31337646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
